Pancreatoduodenectomy in the management of chronic pancreatitis

Arch Surg. 1987 Apr;122(4):416-20. doi: 10.1001/archsurg.1987.01400160042004.

Abstract

The records of 73 consecutive patients who underwent pancreatoduodenectomy for chronic pancreatitis between 1960 and 1985 were reviewed. The median size of the pancreatic duct was 5 mm. Two operative deaths (2.7%) occurred early in the series. Eighty-eight percent, 86%, and 79% of the patients had improvement in pain at six months, two years, and five years, respectively. Diabetes was present preoperatively in 25% of patients and postoperatively in 37%, 45%, and 69% of patients at six months, two years, and five years, respectively. Pancreatic enzyme preparations were used preoperatively by 26% of patients; this use increased to 75% by five years. Only four of 17 late deaths could be related to diabetes or malnutrition. In most patients, pancreatoduodenectomy achieves long-term pain improvement and permits return to normal activities. Selection of patients is important to decrease the late morbidity and mortality.

MeSH terms

  • Adult
  • Aged
  • Calcinosis / surgery
  • Diabetes Mellitus / etiology
  • Duodenum / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Narcotics / therapeutic use
  • Pain / drug therapy
  • Pancreatectomy / adverse effects
  • Pancreatectomy / methods*
  • Pancreatic Ducts / surgery
  • Pancreatic Pseudocyst / surgery
  • Pancreatitis / diagnostic imaging
  • Pancreatitis / surgery*
  • Quality of Life
  • Radiography
  • Reoperation

Substances

  • Narcotics